Overview

Co-leader of Schiff Hardin’s Intellectual Property Group, Imron T. Aly also serves as co-chair of the firm's Pharmaceuticals and Biologics Patent Litigation Team. He focuses his practice in patent infringement and trade secret misappropriation litigation. He has litigated and managed patent infringement and trade secret matters for pharmaceuticals, medical implants and devices, DNA arrays, mechanical production assemblies, computer business methods and financial trading systems.

Previous Experience

Prior to joining Schiff Hardin, Imron was an intellectual property partner in the Chicago office of an international law firm.

  • Experience

    Imron's representative matters prior to joining Schiff Hardin include:

    • Fresenius Kabi USA, LLC v. FERA Pharmaceuticals, LLC (Successfully represented Fresenius Kabi USA, LLC in obtaining a rare preliminary injunction in federal district court. The injunction barred our client’s competitor from launching a generic version of its patented formulation of levothyroxine, an injectable thyroid hormone. The District Court for the District of New Jersey granted the injunction on the basis that our client was likely to win its patent lawsuit against its competitor.)
    • Shire Canada et. al. v. Alkem Laboratories Ltd. (Represented Alkem in lanthanum carbonate ANDA litigation.)
    • King Pharma Inc. and Meridian Medical Technologies Inc v. Teva Pharmaceuticals (Represented Teva in epinephrine injector ANDA litigation.)
    • Aventis Pharma, S.A. and Sanofi-aventis Inc. v. Hospira Inc. (Represented Hospira in defending patent infringement claims for pharmaceutical involving docetaxel for cancer treatments.)
    • Boehringer et al. v. Barr Laboratories (Represented Barr Laboratories in defending patent infringement claims for pharmaceutical involving dipyradimole for stroke prevention.)
    • Sepracor Inc. v. Barr Laboratories Inc. (Representing Barr Laboratories in defending patent infringement claims for pharmaceutical involving levalbuterol for asthma treatments.)
    • Maytag Corporation v. Whirlpool Corp. (Represented Whirlpool in defending patent infringement claims concerning mechanical dispensing systems technology.)
    • Sears v. Bed Bath & Beyond (Represented Sears in patent case regarding electronic gift registry system.)
    • Johnson Controls Inc. v. Lear Corp. (Represented Lear in patent case regarding remote control garage door opener circuitry and encryption.)
    • Intellect Wireless v. Dell Inc. (Represented Dell in patent case involving cellular phone systems.)
    • Nanogen Inc. v. Motorola Inc. (Represented Motorola in a patent litigation concerning biomedical DNA hybridization microchip technology.)
    • Computer Motion Inc. v. Intuitive Surgical Inc. (Represented Computer Motion in patent litigation concerning biomedical surgical robotics devices.)
    • Oxford Gene Technology Ltd. v. Mergen Ltd. (Represented OGT in asserting patent infringement claims concerning DNA hybridization microarray biomedical technology.)
    • Trading Technologies Intl. Inc. v. eSpeed Inc. (Representing eSpeed in defending patent infringement claims for a business-method patent concerning electronic futures trading.)
    • International Game Technology Inc. v. Aristocrat Leisure Ltd. (Represented IGT in a patent litigation focusing on business-method patents for electronic funds management and ticketing systems.)
  • Credentials

    Education

    • Georgetown University Law Center, J.D., 1999, magna cum laude
      Order of the Coif
      Georgetown Journal of Legal Ethics, Senior Articles Editor
    • Duke University, B.S.E., Biomedical Engineering, 1996, cum laude

    Bar Admissions

    • Illinois
    • Missouri
        • U.S. Patent and Trademark Office

          Clerkships

          Hon. Ann K. Covington, Missouri Supreme Court (1999-2000)

          Professional Memberships

          Richard Linn American Inn of Court

          Teaching Appointments

          Guest Lecturer, Patent Litigation, University of Michigan (2011, 2013)

        • Insights

          TITLE
          News Release

          Schiff Hardin Recognized as a Top Hatch-Waxman Defense Firm

          Schiff Hardin LLP has been recognized as one of the top law firms defending Abbreviated New Drug Application (ANDA) litigation in the 2017 Hatch-Waxman/ANDA Litigation Report compiled by legal data analytics firm Lex Machina.

          In The News
          News Release

          Schiff Hardin Expands Global Generic Pharmaceuticals Practice With Addition of Kevin M. Nelson in Chicago

          Schiff Hardin LLP today announced the addition of Kevin M. Nelson as a partner in its rapidly growing Intellectual Property Group.

          In The News
          Trending Legal Issue

          Will The Supreme Court End Venue Shopping In Patent Cases?

          The Supreme Court recently agreed to hear a challenge to the current interpretation of the venue statute in patent infringement cases.

          News Release

          39 Schiff Hardin Lawyers Named to 2017 Illinois Super Lawyers, Rising Stars Lists, and Two Schiff Hardin Attorneys Named to Top 50 Women Lawyers

          Thirty-nine Schiff Hardin attorneys have been selected for inclusion on the 2017 Illinois Super Lawyers and Rising Stars lists.

          In The News
          News Release

          Benchmark Litigation 2017 Recommends Schiff Hardin, Highlights Six Attorneys

          Schiff Hardin is pleased to announce that Benchmark Litigation’s ninth edition honored the firm as a “Recommended Firm” in Illinois.

          Article

          Pharma team scores rare preliminary injunction

          Schiff Hardin’s pharma and life sciences patent litigation team, lead by partner Imron T. Aly, recently secured a preliminary injunction in federal court.

          Trending Legal Issue

          No ‘Speeding Ticket’ for the PTAB

          Supreme Court Holds that Decision to Institute IPR is Non-appealable and PTAB’s “Broadest Reasonable Construction” Standard for Claim Construction is Lawful

          Other Publications

          • "Encouraging Professionalism: The Magic Wand of the Patent Infringement Opinion," Georgetown Journal of Legal Ethics (1999)
          • "Seller Beware: The Scope of the On Sale Bar after Pfaff v. Wells," Texas Intellectual Property Law Journal (1999)

          Speeches & Presentations

          • "New Developments in U.S. Hatch-Waxman Litigation," IP Leadership Forum, New Delhi, India (2014)
          • "Business Method Patents," Software & Information Industry Association, Financial Information Services Division (2002)
        • Citizenship

          Pro Bono Activities

          Imron has represented indigent clients in trademark and copyright, contract dispute, landlord-tenant, prisoner rights and elder abuse matters.

          Civic and Charitable Memberships

          Chicago Committee

          Board Member

           

          Metropolitan Tenants Organization

          Former Board Member

        Product Liability and Mass Torts Blog

        FDA Issues Final Guidance on Biosimilars

        Shortly after approving the first biosimilar under the abbreviated approval pathway created by the Biologics Price Competition and Innovation Act of 2009 (“BPCIA”), the FDA has recently issued 3 final guidances regarding biosimilars. Biological products, or “biologics,” are pharmaceutical products created from biological sources. Unlike chemically synthesized pharmaceuticals, biologics are isolated from natural sources, and...… Continue Reading

        READ

        VISIT THE BLOG
        image description

        Pharma team scores rare preliminary injunction

        Schiff Hardin’s pharma and life sciences patent litigation team, led by partner Imron T. Aly, recently secured a preliminary injunction in federal court. Representing generic drug manufacturer Fresenius Kabi USA, LLC, our team convinced the judge to bar our client’s competitor from launching a generic version of levothyroxine, our client’s patented treatment formulation. MORE